164 related articles for article (PubMed ID: 37172368)
1. Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study.
Sänger JA; Graur A; Tahir I; Price MC; Keane FK; Lanuti M; Sharma A; Fintelmann FJ
Lung Cancer; 2023 Jul; 181():107231. PubMed ID: 37172368
[TBL] [Abstract][Full Text] [Related]
2. Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study.
Fintelmann FJ; Graur A; Oueidat K; Simon J; Barnes JMH; McDermott S; Genshaft SJ; Healey TT; Suh RD; Maxwell AWP; Abtin F
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330300. PubMed ID: 37966037
[No Abstract] [Full Text] [Related]
3. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
[No Abstract] [Full Text] [Related]
4. Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
Leppelmann KS; Levesque VM; Bunck AC; Cahalane AM; Lanuti M; Silverman SG; Shyn PB; Fintelmann FJ
Ann Surg Oncol; 2021 Oct; 28(11):5829-5839. PubMed ID: 33620616
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease.
Kenmotsu H; Yoh K; Mori K; Ono A; Baba T; Fujiwara Y; Yamaguchi O; Ko R; Okamoto H; Yamamoto N; Ninomiya T; Ogura T; Kato T
Cancer Sci; 2019 Dec; 110(12):3738-3745. PubMed ID: 31608537
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S; Ichiyasu H; Ikeda T; Inaba M; Kashiwabara K; Sadamatsu T; Sato N; Akaike K; Okabayashi H; Saruwatari K; Tomita Y; Saeki S; Hirata N; Yoshinaga T; Fujii K
BMC Pulm Med; 2019 Apr; 19(1):72. PubMed ID: 30940113
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.
Yamauchi Y; Izumi Y; Hashimoto K; Yashiro H; Inoue M; Nakatsuka S; Goto T; Anraku M; Ohtsuka T; Kohno M; Kawamura M; Nomori H
PLoS One; 2012; 7(3):e33223. PubMed ID: 22413004
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease.
Shao C; Zhi X; Mao S; Wu L; Yu J; Yang S; Wang W; Jia K; Luo L; Liu X; Jiang T; Zhou F; Chen B; Wang L; Gao G; Shi J; Chen X; Wu F; Ren S
Thorac Cancer; 2024 Apr; 15(10):778-787. PubMed ID: 38400790
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Cryoablation for the Treatment of Recurrent Malignant Pleural Mesothelioma: Safety, Early-Term Efficacy, and Predictors of Local Recurrence.
Abtin F; Quirk MT; Suh RD; Hsu W; Han SX; Kim GJ; Genshaft S; Sandberg JK; Olevsky O; Cameron RB
J Vasc Interv Radiol; 2017 Feb; 28(2):213-221. PubMed ID: 27979596
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.
Choi MK; Hong JY; Chang W; Kim M; Kim S; Jung HA; Lee SJ; Park S; Chung MP; Sun JM; Park K; Ahn MJ; Ahn JS
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1217-25. PubMed ID: 24696125
[TBL] [Abstract][Full Text] [Related]
11. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease.
Okuda K; Hirose T; Oki Y; Murata Y; Kusumoto S; Sugiyama T; Ishida H; Shirai T; Nakashima M; Yamaoka T; Ohnishi T; Ohmori T
Anticancer Res; 2012 Dec; 32(12):5475-80. PubMed ID: 23225454
[TBL] [Abstract][Full Text] [Related]
13. Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer.
Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
Thorac Cancer; 2021 Mar; 12(5):667-675. PubMed ID: 33480111
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-guided cryoablation for adrenal metastases secondary to lung cancer.
Zhang WL; Ruan DL; Sun LJ; Wang T; Zhang W; Huang YY
J Cancer Res Ther; 2021 Nov; 17(5):1269-1274. PubMed ID: 34850777
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab.
Yamaguchi O; Kaira K; Shinomiya S; Mouri A; Hashimoto K; Shiono A; Miura Y; Akagami T; Imai H; Kobayashi K; Kagamu H
Thorac Cancer; 2021 Feb; 12(3):304-313. PubMed ID: 33185333
[TBL] [Abstract][Full Text] [Related]
16. Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease.
Kenmotsu H; Naito T; Mori K; Ko R; Ono A; Wakuda K; Imai H; Taira T; Murakami H; Endo M; Takahashi T
Cancer Chemother Pharmacol; 2015 Mar; 75(3):521-6. PubMed ID: 25563718
[TBL] [Abstract][Full Text] [Related]
17. Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis.
Wrobel MM; Bourgouin PP; Abrishami Kashani M; Leppelmann KS; Vazquez R; Pachamanova DA; Fintelmann FJ
AJR Am J Roentgenol; 2021 Nov; 217(5):1153-1163. PubMed ID: 34008999
[No Abstract] [Full Text] [Related]
18. Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease.
Saito T; Ohnishi K; Ishikawa H; Nakamura M; Hoshiai S; Numajiri H; Murofushi KN; Mizumoto M; Okumura T; Sakurai H
Anticancer Res; 2021 Nov; 41(11):5635-5642. PubMed ID: 34732436
[TBL] [Abstract][Full Text] [Related]
19. Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease.
Tasaka Y; Honda T; Nishiyama N; Tsutsui T; Saito H; Watabe H; Shimaya K; Mochizuki A; Tsuyuki S; Kawahara T; Sakakibara R; Mitsumura T; Okamoto T; Kobayashi M; Chiaki T; Yamashita T; Tsukada Y; Taki R; Jin Y; Sakashita H; Natsume I; Saitou K; Miyashita Y; Miyazaki Y
Lung Cancer; 2021 May; 155():120-126. PubMed ID: 33798901
[TBL] [Abstract][Full Text] [Related]
20. Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease.
Shibaki R; Murakami S; Matsumoto Y; Goto Y; Kanda S; Horinouchi H; Fujiwara Y; Yamamoto N; Motoi N; Kusumoto M; Yamamoto N; Ohe Y
Med Oncol; 2019 Apr; 36(6):49. PubMed ID: 31030326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
